4
Changes in Ownership
CERUS CORP Filed Acc 0001209191-22-019064
Chief Scientific Officer sold 30,307 shares at $5.04 ($152,735)
- Chief Scientific Officer acquired 84,437 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| CORASH LAURENCE M Chief Scientific Officer | 2022-03-12 | Option exercise | +45,000 | 2,117,586 | D: show line 1 in the form | ||
| CORASH LAURENCE M Chief Scientific Officer | 2022-03-14 | Sale | −16,152 | $5.04 | $81,400 | 2,101,434 | D: show line 2 in the form |
| CORASH LAURENCE M Chief Scientific Officer | 2022-03-12 | Option exercise | +22,770 | 2,124,204 | D: show line 3 in the form | ||
| CORASH LAURENCE M Chief Scientific Officer | 2022-03-14 | Sale | −8,173 | $5.04 | $41,189 | 2,116,031 | D: show line 4 in the form |
| CORASH LAURENCE M Chief Scientific Officer | 2022-03-12 | Option exercise | +16,667 | 2,132,698 | D: show line 5 in the form | ||
| CORASH LAURENCE M Chief Scientific Officer | 2022-03-14 | Sale | −5,982 | $5.04 | $30,147 | 2,126,716 | D: show line 6 in the form |
| Open-market sales · 30,307 sh · avg $5.04 · $152,735 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| CORASH LAURENCE M Chief Scientific Officer | 2022-03-12 | Option exercise · Restricted Stock Unit | −45,000 | 0 | D: show line 7 in the form | |||||
| CORASH LAURENCE M Chief Scientific Officer | 2022-03-12 | Option exercise · Restricted Stock Unit | −22,770 | 23,460 | D: show line 8 in the form | |||||
| CORASH LAURENCE M Chief Scientific Officer | 2022-03-12 | Option exercise · Restricted Stock Unit | −16,667 | 33,333 | D: show line 9 in the form |
Loading xslF345X03/doc4.xml…